GSDME and neoplasm: Combining decitabine (DAC) with chemotherapy nanodrugs to manage drugs to activate and upregulate the caspase‐3/GSDME signal, further triggers pyroptosis in tumor cells, therefore strengthening the immunological effect of chemotherapy with cisplatin in a mouse triple‐negative breast cancer model.